Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan 18;107(2):e888-e889.
doi: 10.1210/clinem/dgab736.

Letter to the Editor From Sävendahl et al.: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial"

Lars Sävendahl  1 , Tadej Battelino  2 , Meryl Brod  3 , Michael Højby Rasmussen  4 , Rasmus Juul Kildemoes  4 , Paul Saenger  5
Affiliations
Comment

Letter to the Editor From Sävendahl et al.: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial"

Lars Sävendahl et al. J Clin Endocrinol Metab. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Thornton PS, Maniatis AK, Aghajanova E, et al. . Weekly lonapegsomatropin in treatment-naïve children with growth hormone deficiency: the phase 3 heiGHt trial. J Clin Endocrinol Metab. 2021:dgab529. doi:10.1210/clinem/dgab529 - DOI - PMC - PubMed
    1. Sävendahl L, Battelino T, Brod M, et al. . Once-weekly somapacitan vs daily GH in children with GH deficiency: results from a randomized phase 2 trial. J Clin Endocrinol Metab. 2020;105(4):e1847-e1861. - PMC - PubMed
    1. Yuen KCJ, Miller BS, Boguszewski CL, Hoffman AR. Usefulness and potential pitfalls of long-acting growth hormone analogs. Front Endocrinol (Lausanne). 2021;12:637209. - PMC - PubMed